TABLE 2.
Active ingredients | Source | Experimental model | Dose/concentration | Efficiency | Molecular targets | Signaling pathway | References |
---|---|---|---|---|---|---|---|
Berberine | Coptis chinensis Franch. | HFD fed 8-week-old male ApoE−/− mice | 78,117,156 mg/kg | Regulate blood lipid; Induce autophagy | Beclin-1↓ p62↓ | PI3K/AKT/mTOR | Song and Chen, (2021) |
p-PI3K↑ | |||||||
p-mTOR↑ | |||||||
p-AKT↓ | |||||||
Berberine | // | Murine cell line J774A incubated with ox-LDL | 25,50 μM | Induce autophagy; Reduce inflammation | LC3 II/I↑ SQSTM1/p62↓ | AMPK/mTOR | Fan et al. (2015) |
Berberine (sonodynamic therapy) | // | Human THP-1 monocytes | 30 μg/mL | Induce autophagy; Regulate cholesterol efflux | LC3-II/I↑ p62↓ | PI3K/AKT/mTOR | Kou et al. (2017) |
Matrine | Sophora flavescens Aiton | AGE- induced HCSMCs | 0,0.25,0.5,0.75 and 1.0mmol/L | Suppress fibrotic response | PI3K↓ | PI3K/AKT/mTOR/p70S6k | Ma et al. (2019) |
↑, upgrade; ↓, downgrade.